Modeling the mitochondrial cardiomyopathy of Barth syndrome with iPSC and heart-on-chip technologies
暂无分享,去创建一个
Gang Wang | Ronald J A Wanders | Kevin Kit Parker | Aibin He | Hongyan Yuan | Kenneth R Chien | Donghui Zhang | George M Church | Lior Zangi | Kai Li | Ashutosh Agarwal | Megan L. McCain | G. Church | G. Wang | Da-Zhi Wang | Aibin He | W. Pu | R. Wanders | K. Parker | Luhan Yang | K. Chien | A. Roberts | Judith Geva | F. Pasqualini | A. Agarwal | W. Kulik | Hongyan Yuan | R. Kelley | Jinghai Chen | C. Murry | M. Laflamme | L. Zangi | Luhan Yang | Charles E Murry | D. Jiang | Da-Zhi Wang | William T Pu | Amy E Roberts | Wim Kulik | Dawei Jiang | Jinghai Chen | Donghui Zhang | Qing Ma | Jian Ding | Kai Li | Jiwu Wang | F. Vaz | Richard I Kelley | Qing Ma | Frédéric M Vaz | Megan L McCain | Francesco Silvio Pasqualini | Judith Geva | Jian Ding | Jiwu Wang | Michael A Laflamme
[1] G. Stoney. The Tension of Metallic Films Deposited by Electrolysis , 1909 .
[2] J. Haselgrove,et al. Diagnosis and therapeutic evaluation of a pediatric case of cardiomyopathy using phosphorus-31 nuclear magnetic resonance spectroscopy. , 1985, Journal of the American College of Cardiology.
[3] Avraham A. Melkman,et al. On-Line Construction of the Convex Hull of a Simple Polyline , 1987, Inf. Process. Lett..
[4] A. Gerdes,et al. Structural remodeling and mechanical dysfunction of cardiac myocytes in heart failure. , 1995, Journal of molecular and cellular cardiology.
[5] E. Maestrini,et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.
[6] C. S. Chen,et al. Geometric control of cell life and death. , 1997, Science.
[7] Guido Gerig,et al. Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images , 1998, Medical Image Anal..
[8] J. Towbin,et al. Novel Gene Mutations in Patients With Left Ventricular Noncompaction or Barth Syndrome , 2001, Circulation.
[9] S. Dimauro,et al. Phospholipid abnormalities in children with Barth syndrome. , 2003, Journal of the American College of Cardiology.
[10] Patrick Rodriguez,et al. Efficient biotinylation and single-step purification of tagged transcription factors in mammalian cells and transgenic mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] R. Wanders,et al. Linoleic acid supplementation of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment. , 2003, Journal of lipid research.
[12] N. Copeland,et al. A highly efficient recombineering-based method for generating conditional knockout mutations. , 2003, Genome research.
[13] Houping Ni,et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. , 2005, Immunity.
[14] G. Whitesides,et al. Muscular Thin Films for Building Actuators and Powering Devices , 2007, Science.
[15] T. Ichisaka,et al. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.
[16] G. Sparagna,et al. Role of cardiolipin alterations in mitochondrial dysfunction and disease. , 2007, American journal of physiology. Cell physiology.
[17] R. Wanders,et al. Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome. , 2008, Clinical chemistry.
[18] Hiroki Kato,et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] Kevin Kit Parker,et al. Myofibrillar Architecture in Engineered Cardiac Myocytes , 2008, Circulation research.
[20] T. Ichisaka,et al. Induction of Pluripotent Stem Cells From Adult Human Fibroblasts by Defined Factors , 2008 .
[21] Sean P Sheehy,et al. Sarcomere alignment is regulated by myocyte shape. , 2008, Cell motility and the cytoskeleton.
[22] George Q. Daley,et al. Disease-Specific Induced Pluripotent Stem Cells , 2008, Cell.
[23] Kevin Kit Parker,et al. Generation of Functional Ventricular Heart Muscle from Mouse Ventricular Progenitor Cells , 2009, Science.
[24] G. Daley,et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells , 2009, Nature Biotechnology.
[25] M. Schlame,et al. Role of calcium-independent phospholipase A2 in the pathogenesis of Barth syndrome , 2009, Proceedings of the National Academy of Sciences.
[26] D. G. Gibson,et al. Enzymatic assembly of DNA molecules up to several hundred kilobases , 2009, Nature Methods.
[27] R. Wanders,et al. The enigmatic role of tafazzin in cardiolipin metabolism. , 2009, Biochimica et biophysica acta.
[28] R. Wanders,et al. Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. , 2009, Analytical biochemistry.
[29] Sheng Wei,et al. T-Tubule Remodeling During Transition From Hypertrophy to Heart Failure , 2010, Circulation research.
[30] Sean P Sheehy,et al. Biohybrid thin films for measuring contractility in engineered cardiovascular muscle. , 2010, Biomaterials.
[31] Alexander Meissner,et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. , 2010, Cell stem cell.
[32] Erin L. Doyle,et al. Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting , 2011, Nucleic acids research.
[33] K. L. de Mesy Bentley,et al. The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. , 2011, Developmental cell.
[34] Raphael Cohen,et al. CHILD: a new tool for detecting low-abundance insertions and deletions in standard sequence traces , 2011, Nucleic acids research.
[35] Shinya Yamanaka,et al. Efficient and Scalable Purification of Cardiomyocytes from Human Embryonic and Induced Pluripotent Stem Cells by VCAM1 Surface Expression , 2011, PloS one.
[36] B. Lask,et al. Implications for Treatment , 2011 .
[37] Megan L. McCain,et al. Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip. , 2011, Lab on a chip.
[38] Aibin He,et al. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart , 2011, Proceedings of the National Academy of Sciences.
[39] Samira Kiani,et al. Genetic engineering of human ES and iPS cells using TALE nucleases , 2011, Nature Biotechnology.
[40] R. Passier,et al. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes , 2011, Nature Methods.
[41] Xi-rong Guo,et al. Feeder-Free Derivation of Human Induced Pluripotent Stem Cells with Messenger RNA , 2012, Scientific Reports.
[42] Yvonne Will,et al. Characterization of human-induced pluripotent stem cell-derived cardiomyocytes: bioenergetics and utilization in safety screening. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.
[43] Euan A. Ashley,et al. Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy , 2012, Science Translational Medicine.
[44] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[45] Rudolf Jaenisch,et al. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering , 2013, Cell.
[46] S. Steinberg. Oxidative Stress and Sarcomeric Proteins , 2013, Circulation research.
[47] David A. Scott,et al. Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity , 2013, Cell.
[48] George Church,et al. Optimization of scarless human stem cell genome editing , 2013, Nucleic acids research.
[49] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[50] Euan A Ashley,et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells. , 2013, Cell stem cell.
[51] Ronald A. Li,et al. Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction , 2013, Nature Biotechnology.
[52] F. Rivier,et al. Natural history of Barth syndrome: a national cohort study of 22 patients , 2013, Orphanet Journal of Rare Diseases.
[53] Josue A. Goss,et al. Microfluidic heart on a chip for higher throughput pharmacological studies. , 2013, Lab on a chip.
[54] G. Church,et al. CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering , 2013, Nature Biotechnology.
[55] Murim Choi,et al. De novo mutations in histone modifying genes in congenital heart disease , 2013, Nature.
[56] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[57] G. Dorn,et al. PINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria , 2013, Science.
[58] Gang Bao,et al. Quantifying genome-editing outcomes at endogenous loci with SMRT sequencing. , 2014, Cell reports.
[59] V. Iyer,et al. Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects , 2014, Nature Methods.
[60] B. Conklin,et al. Isolation of single-base genome-edited human iPS cells without antibiotic selection , 2014, Nature Methods.